[go: up one dir, main page]

FR2869229A1 - Utilisation d'un inducteur des ugt par voie topique - Google Patents

Utilisation d'un inducteur des ugt par voie topique

Info

Publication number
FR2869229A1
FR2869229A1 FR0404408A FR0404408A FR2869229A1 FR 2869229 A1 FR2869229 A1 FR 2869229A1 FR 0404408 A FR0404408 A FR 0404408A FR 0404408 A FR0404408 A FR 0404408A FR 2869229 A1 FR2869229 A1 FR 2869229A1
Authority
FR
France
Prior art keywords
ugt
inducer
topic
skin
protecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR0404408A
Other languages
English (en)
Other versions
FR2869229B1 (fr
Inventor
Karl Lintner
Chamberlin Claire Mas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sederma SA
Original Assignee
Sederma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sederma SA filed Critical Sederma SA
Priority to FR0404408A priority Critical patent/FR2869229B1/fr
Priority to EP05718804.7A priority patent/EP1776161B1/fr
Priority to US11/587,533 priority patent/US8530426B2/en
Priority to PCT/IB2005/051344 priority patent/WO2005102266A1/fr
Publication of FR2869229A1 publication Critical patent/FR2869229A1/fr
Application granted granted Critical
Publication of FR2869229B1 publication Critical patent/FR2869229B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention a pour objet l'utilisation topique d'au moins un inducteur d'UGT dans ou pour la préparation d'une composition contenant un milieu dermatologiquement acceptable pour protéger et/ou améliorer l'état de la peau, prévenir et/ou traiter les imperfections de la peau.
FR0404408A 2004-04-26 2004-04-26 Utilisation d'un inducteur des ugt par voie topique Expired - Lifetime FR2869229B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0404408A FR2869229B1 (fr) 2004-04-26 2004-04-26 Utilisation d'un inducteur des ugt par voie topique
EP05718804.7A EP1776161B1 (fr) 2004-04-26 2005-04-25 Composition cosmetique ou dermopharmaceutique comprenant au moins un inducteur d'enzymes udp-glucuronosyltransferases (ugt)
US11/587,533 US8530426B2 (en) 2004-04-26 2005-04-25 Cosmetic or dermopharmaceutical composition comprising at least one UDP glucuronosyl transferase (UGT) enzymes inducer
PCT/IB2005/051344 WO2005102266A1 (fr) 2004-04-26 2005-04-25 Composition cosmetique ou dermopharmaceutique comprenant au moins un inducteur d'enzymes udp-glucuronosyltransferases (ugt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0404408A FR2869229B1 (fr) 2004-04-26 2004-04-26 Utilisation d'un inducteur des ugt par voie topique

Publications (2)

Publication Number Publication Date
FR2869229A1 true FR2869229A1 (fr) 2005-10-28
FR2869229B1 FR2869229B1 (fr) 2006-08-25

Family

ID=34945748

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0404408A Expired - Lifetime FR2869229B1 (fr) 2004-04-26 2004-04-26 Utilisation d'un inducteur des ugt par voie topique

Country Status (4)

Country Link
US (1) US8530426B2 (fr)
EP (1) EP1776161B1 (fr)
FR (1) FR2869229B1 (fr)
WO (1) WO2005102266A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2898491A1 (fr) * 2006-03-16 2007-09-21 Seppic Sa Procede pour reduire l'odeur induite par les lipoaminoacides dans les formulations topiques cosmetiques et/ou pharmaceutiques et formulations a faible odeur
FR2919501A1 (fr) * 2007-08-02 2009-02-06 Oreal Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2836042B1 (fr) * 2002-02-15 2004-04-02 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour diminuer les poches et cernes sous les yeux
FR2843023B1 (fr) * 2002-07-30 2004-09-24 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant du kombucha.
FR2885522B1 (fr) * 2005-05-13 2020-01-10 Sederma Composition cosmetique ou dermopharmaceutique contenant de la teprenone
FR2890310B1 (fr) 2005-09-06 2009-04-03 Sederma Soc Par Actions Simpli Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee
CN101400787B (zh) * 2006-01-27 2013-01-23 株式会社Prostemics 采用脂肪来源成体干细胞大量制造生长因子的方法
FR2900573B1 (fr) * 2006-05-05 2014-05-16 Sederma Sa Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque
GB0614353D0 (en) * 2006-07-20 2006-08-30 Oraldent Ltd Oral compositions, their preparation and use
FR2904549B1 (fr) * 2006-08-03 2012-12-14 Sederma Sa Composition comprenant de la sarsasapogenine
US20080075798A1 (en) * 2006-08-30 2008-03-27 Rosemarie Osborne Personal care compositions comprising pear seed extract
US20080059313A1 (en) * 2006-08-30 2008-03-06 Oblong John E Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
FR2906716B1 (fr) * 2006-10-06 2013-05-17 Clarins Lab Utilisation d'une composition cosmetique pour le soin des peaux grasses.
US20080124306A1 (en) * 2006-11-28 2008-05-29 Kiminobu Sugaya Vigor Enhancement Via Administration of Pyrimidine Derivatives
CN101815502B (zh) * 2007-09-04 2013-10-09 欧莱雅 橙皮苷和微生物的组合在影响皮肤的屏障功能中的用途
MX2010009371A (es) * 2008-02-29 2010-09-14 Procter & Gamble Composiciones para el cuidado del pelo y metodos para incrementar el diametro del pelo.
US9005644B2 (en) * 2008-04-11 2015-04-14 Basf Corporation Pesticidal compositions
US7842725B2 (en) 2008-07-24 2010-11-30 Ecolab USA, Inc. Foaming alcohol compositions with selected dimethicone surfactants
US20100080768A1 (en) * 2008-09-26 2010-04-01 Mcgraw Thomas L Compositions and Methods for the Treatment of Inflammatory Dermatosis and Other Pathological Conditions of the Skin
KR20100084399A (ko) * 2009-01-16 2010-07-26 학교법인 동의학원 나노입자 형태로 세드롤을 포함하는 항암 조성물
US20100303745A1 (en) * 2009-05-29 2010-12-02 Brownberry Skin bronzer
WO2011123619A2 (fr) * 2010-03-31 2011-10-06 Penguin Ip Holdings Inc. Mélanges perméables, procédés et compositions pour la peau
FR2958641B1 (fr) 2010-04-08 2014-12-26 Sederma Sa Nouveaux composes de type polyterpenique, compositions cosmetiques, nutraceutiques et pharmaceutiques les contenant et utilisations dans ces domaines.
US8828453B2 (en) * 2010-04-29 2014-09-09 Betul Hatipoglu Herbal-based compositions for alleviating symptoms associated with autism
WO2011144536A1 (fr) 2010-05-18 2011-11-24 Unilever Nv Composition de soins personnels
US20120045405A1 (en) * 2010-08-18 2012-02-23 Gilman Miles E Under eye cream
WO2012097061A1 (fr) * 2011-01-13 2012-07-19 Abbott Laboratories Compositions nutritionnelles et procédés pour améliorer le métabolisme protéique des muscles squelettiques
FR2970868B1 (fr) 2011-01-31 2023-10-27 Sederma Sa Extrait d'origine vegetale, composition le contenant, procede d'obtention par culture vegetale et utilisations dans les domaines cosmetique, pharmaceutique et cosmeceutique
FR2974297B1 (fr) 2011-04-21 2013-10-04 Sederma Sa Nouvelle utilisation cosmetique ou therapeutique du tripeptide ghk
US8841350B2 (en) 2011-05-11 2014-09-23 ChromaDex Inc. Method for inducing UDP-glucuronosyltransferase activity using pterostilbene
FR2975904B1 (fr) 2011-06-01 2013-08-23 Sederma Sa Nouvelle utilisation topique, cosmetique ou dermopharmaceutique, d'un melange comprenant un tripeptide du type ghk et un tetrapeptide du type gqpr
FR2978351B1 (fr) 2011-07-28 2014-02-21 Sederma Sa Materiel d'origine vegetale, composition le contenant, et utilisation topique cosmetique
KR102142311B1 (ko) * 2011-12-16 2020-08-10 (주)아모레퍼시픽 텐저레틴을 함유하는 피부 외용제 조성물
FR2985424B1 (fr) 2012-01-10 2019-03-29 Sederma Nouvelle utilisation topique de la zerumbone
FR2997299B1 (fr) 2012-10-30 2014-12-26 Sederma Sa Association d'extraits de plantes, ingredient actif cosmetique et composition les contenant, et utilisation topique cosmetique
WO2014095289A2 (fr) * 2012-12-20 2014-06-26 Unilever Plc Méthode de traitement du vieillissement capillaire
WO2014167464A1 (fr) 2013-04-08 2014-10-16 Sederma Procédé de production de cellules méristématiques de plantago lanceolata, composition comprenant lesdites cellules ou leur extrait cellulaire et ses utilisations cosmétiques, nutraceutiques et dermatologiques
US10123966B2 (en) 2013-05-16 2018-11-13 The Procter And Gamble Company Hair thickening compositions and methods of use
US9744116B2 (en) 2013-09-18 2017-08-29 L'oreal High color intensity and easily removable mascara
DE102014217490A1 (de) * 2014-09-02 2016-03-03 Beiersdorf Ag Verwendung von Gossypetin und/oder Gossypin gegen Hautalterung
US10413528B2 (en) 2014-10-20 2019-09-17 John H. Plumb Methods to inhibit infection during wound healing with topical compositions including amino acids
KR101645531B1 (ko) * 2014-10-23 2016-08-04 주식회사 엘지생활건강 게니스테인 및 다이드제인을 함유하는 액정젤 및 이를 포함하는 항노화용 화장료 조성물
FR3029417B1 (fr) * 2014-12-08 2017-01-06 Franck Margnat Complexe actif pour un produit cosmetique contre le vieillissement cutane
FR3031454B1 (fr) 2015-01-13 2018-05-11 Sederma Utilisation de cellules vegetales de leontopodium alpinum pour un traitement cosmetique et ingredient actif cosmetique correspondant
US10034825B2 (en) * 2015-07-01 2018-07-31 Jan Marini Skin Research Luminate eye gel
CA2997220A1 (fr) * 2015-09-03 2017-03-09 Delivra Inc. Formulations transdermiques pour l'administration de doxycycline et leur utilisation dans le traitement de maladies et de pathologies sensibles a la doxycycline
WO2017045081A1 (fr) * 2015-09-18 2017-03-23 Delivra Inc. Formulations transdermiques pour l'administration d'ains à base d'acide propionique et acétique et leur utilisation dans le traitement de maladies et de pathologies sensibles aux ains
CN105213274B (zh) * 2015-11-11 2018-07-17 大兴安岭至臻尚品寒带生物技术有限公司 天然植物营养素和细胞生长修复因子的护肤品
WO2017136600A1 (fr) 2016-02-04 2017-08-10 ALASTIN Skincare, Inc. Compositions et méthodes pour procédures invasives et non invasives de soins cutanés
WO2018078412A1 (fr) * 2016-10-31 2018-05-03 Posi Visionary Solutions Llp Microémulsion topique de diosmétine et utilisations de celle-ci
WO2018237218A1 (fr) 2017-06-23 2018-12-27 The Procter & Gamble Company Composition et procédé permettant d'améliorer l'aspect de la peau
CN111182914A (zh) 2017-08-03 2020-05-19 阿拉斯廷护肤公司 用于改善皮肤松弛和身体轮廓的组合物和方法
US10264787B1 (en) 2017-11-28 2019-04-23 BIOVECBLOK s.r.l. Natural mosquito larvicide
US10306894B1 (en) 2017-11-28 2019-06-04 BIOVECBLOK s.r.l. Natural mosquito repellant
WO2019190531A1 (fr) * 2018-03-29 2019-10-03 Sanova Bioscience, Inc. Films cosmétiques à base de collagène à dissolution rapide et leurs procédés
EP3817717A1 (fr) 2018-07-03 2021-05-12 The Procter & Gamble Company Méthode de traitement d'une affection cutanée
RU2683248C1 (ru) * 2018-07-24 2019-03-27 Виктория Михайловна Суслова Композиция лосьона для ухода после бритья за кожей лица, имеющей угревые высыпания
WO2020028694A1 (fr) 2018-08-02 2020-02-06 ALASTIN Skincare, Inc. Compositions liposomales et procédés d'utilisation
CN113038920A (zh) * 2018-09-20 2021-06-25 陶托纳集团知识产权控股有限责任公司 用于治疗美学皮肤病症的铁螯合化合物
KR102644611B1 (ko) * 2018-11-29 2024-03-07 (주)아모레퍼시픽 탈모 또는 피부 염증 억제용 조성물
WO2020202764A1 (fr) * 2019-04-05 2020-10-08 株式会社 資生堂 Activateur cellulaire
WO2020204193A1 (fr) 2019-04-05 2020-10-08 株式会社 資生堂 Composition comprenant une substance de conversion de longueur d'onde ultraviolette
FR3099993B1 (fr) * 2019-08-22 2021-09-10 Laboratoires Cinq Mondes Composition cosmetique
FR3101544B1 (fr) * 2019-10-07 2023-09-29 Sederma Sa Traitement cosmétique ou dermatologique a base de peptide(s) de la peau et de ses phanères
US20230018704A1 (en) * 2019-12-05 2023-01-19 Kao Corporation Hair cosmetic composition
FR3104973B1 (fr) * 2019-12-20 2022-07-22 Sederma Sa Composition cosmétique ou dermatologique agissant notamment sur les effets de la lumière bleue sur la peau et ses phanères, et utilisations associées
JPWO2021153783A1 (fr) 2020-01-31 2021-08-05
FR3107708B1 (fr) 2020-02-28 2025-03-07 Alganelle Microalgue recombinante capable de produire des peptides, polypeptides et protéines de KTTKS et leurs dérivés, et leurs procédé et utilisations associés
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
JP7590462B2 (ja) 2020-06-01 2024-11-26 ザ プロクター アンド ギャンブル カンパニー ビタミンｂ３化合物の皮膚への浸透を改善する方法
US12472129B2 (en) 2020-07-06 2025-11-18 Ecolab Usa Inc. Foaming mixed alcohol/water compositions comprising a structured alkoxylated siloxane
WO2022010893A1 (fr) 2020-07-06 2022-01-13 Ecolab Usa Inc. Compositions d'alcool/eau mélangées moussantes comprenant une combinaison d'alkylsiloxane et d'un hydrotrope/solubilisant
US12152220B2 (en) 2020-07-06 2024-11-26 Ecolab Usa Inc. PEG-modified castor oil based compositions for microemulsifying and removing multiple oily soils
WO2022013868A1 (fr) 2020-07-13 2022-01-20 Nsc Nano Sono Cooperation Ltd. Formulations topiques anti-microbiennes anhydres et leurs méthodes d'utilisation
US11793746B2 (en) * 2020-10-01 2023-10-24 Chanda Zaveri Intense skin hydration systems and methods
DE102020215081B4 (de) * 2020-11-30 2025-02-06 Henkel Ag & Co. Kgaa Pulverförmiges kosmetisches Reinigungsmittel
CN113693999A (zh) * 2020-12-10 2021-11-26 洛里·安妮·玛丽·米亚斯 一种用于溶解到流体化妆品中的固态组合物和流体化妆品
EP4205727A1 (fr) * 2021-12-31 2023-07-05 Sislan (Zhuhai) Pharmaceutical Technology Co., Ltd Composition déodorante à faible irritation cutanée, et son procédé de préparation
CA3246152A1 (fr) * 2022-03-25 2023-09-28 Curology, Inc. Compositions et méthodes destinées au traitement de l'acné et du photovieillissement
CN115290805B (zh) * 2022-08-23 2024-07-23 陕西省中医药研究院 一种凤尾七药材指纹图谱方法及含量检测方法
WO2024073699A1 (fr) * 2022-09-29 2024-04-04 Muhammed Majeed Compositions pour traiter l'hirsutisme
AU2024268664A1 (en) * 2023-05-10 2025-11-27 Debut Biotechnology, Inc. Formulations of naringenin

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2594336A1 (fr) * 1985-09-03 1987-08-21 Brevier Christiane Propolis : substance naturelle, purifiee, employee en agro-alimentaire, agriculture, cosmetiques, dermatologie, produits d'hygiene
FR2778663A1 (fr) * 1998-05-15 1999-11-19 Coletica Nouveaux esters de flavonoides,leur utilisation en cosmetique, dermopharmacie, en pharmacie et en agro-alimentaire
WO2000067767A1 (fr) * 1999-05-05 2000-11-16 Pierre Fabre Dermo-Cosmetique Extrait de bourgeons de peuplier et son association avec le squalane comme medicament anti-inflammatoire
JP2000319154A (ja) * 1999-05-06 2000-11-21 Nippon Menaade Keshohin Kk 光毒性抑制剤
KR20010009474A (ko) * 1999-07-09 2001-02-05 김박광 크라이신 7-ｏ-크로토네이트 및 이를 함유한 육모제용 조성물
FR2802413A1 (fr) * 1999-12-17 2001-06-22 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant le tripeptide n-palmytoyl-gly-hys-lys, pour eliminer, reduire ou prevenir l'apparition de rides quelles qu'en soient la localisation et la cause
DE10009424A1 (de) * 2000-02-28 2001-09-06 Henkel Kgaa Verwendung von Flavonen oder Isoflavonen zur Cellulite-Behandlung
EP1300138A2 (fr) * 1994-12-13 2003-04-09 Beiersdorf AG Agents efficaces contre des états cutanés déficients hyper-réactifs et hypo-actifs et des dermatites manifestes
FR2836042A1 (fr) * 2002-02-15 2003-08-22 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour diminuer les poches et cernes sous les yeux
WO2004089392A1 (fr) * 2003-04-04 2004-10-21 Unigen Pharmaceuticals, Inc. Formulation destinee a inhiber la cyclooxygenase (cox) et la lipoxygenase (lox) utilisee dans les soins cutanes

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
DE10050155A1 (de) * 2000-10-11 2002-04-18 Beiersdorf Ag Kosemtische und dermatologische Zubereitungen mit einem Gehalt an Desferrioxamin
FR2821086B1 (fr) * 2001-02-21 2003-12-12 Sederma Sa Procede de fabrication de proteines par fermentation de microorganismes de la famille thermus, melange de proteines ainsi obtenu et composition cosmetique les contenant
US20020182237A1 (en) * 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
US7192586B2 (en) * 2001-09-20 2007-03-20 Cornell Research Foundation, Inc. Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate specific membrane antigen
FR2830195B1 (fr) * 2001-10-03 2004-10-22 Sederma Sa Compositions cosmetiques et dermopharmaceutiques pour les peaux a tendance acneique
US20030147830A1 (en) * 2002-01-30 2003-08-07 The Procter & Gamble Company Topical skin and/or hair compositions containing protein
FR2841550B1 (fr) * 2002-06-26 2007-05-04 Sederma Sa Nouvelles molecules derivees de la tyramine, leur mode de preparation, et leur utilisation seules ou associees dans des compositions cosmetiques ou dermopharmceutiques
FR2843023B1 (fr) * 2002-07-30 2004-09-24 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant du kombucha.
FR2854897B1 (fr) * 2003-05-12 2007-05-04 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
WO2004103334A1 (fr) * 2003-05-20 2004-12-02 Sederma Composition cosmetique amincissante contenant du cafestol et du kahweoel
FR2880802B1 (fr) * 2005-01-14 2008-12-19 Sederma Soc Par Actions Simpli Composition cosmetique ou dermopharmaceutique contenant un extrait d'euglene
US20060067905A1 (en) * 2005-04-01 2006-03-30 Sederma Sas Formulations and method for treating baldness
ATE524486T1 (de) * 2005-04-27 2011-09-15 Sederma S A S Lys-thr-dipeptide und deren verwendung
FR2885522B1 (fr) * 2005-05-13 2020-01-10 Sederma Composition cosmetique ou dermopharmaceutique contenant de la teprenone
FR2890310B1 (fr) * 2005-09-06 2009-04-03 Sederma Soc Par Actions Simpli Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee
ES2638242T3 (es) * 2006-02-16 2017-10-19 Sederma Polipéptidos KXK y su uso
FR2900573B1 (fr) * 2006-05-05 2014-05-16 Sederma Sa Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque
FR2904549B1 (fr) * 2006-08-03 2012-12-14 Sederma Sa Composition comprenant de la sarsasapogenine
FR2920967B1 (fr) * 2007-09-14 2009-10-23 Sederma Soc Par Actions Simpli Utilisation de l'hydroxymethionine en tant qu'actif anti age
FR2927801B1 (fr) * 2008-02-22 2010-03-05 Sederma Sa Composition cosmetique hydratante comprenant une combinaison d'homarine et d'erythritol

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2594336A1 (fr) * 1985-09-03 1987-08-21 Brevier Christiane Propolis : substance naturelle, purifiee, employee en agro-alimentaire, agriculture, cosmetiques, dermatologie, produits d'hygiene
EP1300138A2 (fr) * 1994-12-13 2003-04-09 Beiersdorf AG Agents efficaces contre des états cutanés déficients hyper-réactifs et hypo-actifs et des dermatites manifestes
FR2778663A1 (fr) * 1998-05-15 1999-11-19 Coletica Nouveaux esters de flavonoides,leur utilisation en cosmetique, dermopharmacie, en pharmacie et en agro-alimentaire
WO2000067767A1 (fr) * 1999-05-05 2000-11-16 Pierre Fabre Dermo-Cosmetique Extrait de bourgeons de peuplier et son association avec le squalane comme medicament anti-inflammatoire
JP2000319154A (ja) * 1999-05-06 2000-11-21 Nippon Menaade Keshohin Kk 光毒性抑制剤
KR20010009474A (ko) * 1999-07-09 2001-02-05 김박광 크라이신 7-ｏ-크로토네이트 및 이를 함유한 육모제용 조성물
FR2802413A1 (fr) * 1999-12-17 2001-06-22 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant le tripeptide n-palmytoyl-gly-hys-lys, pour eliminer, reduire ou prevenir l'apparition de rides quelles qu'en soient la localisation et la cause
DE10009424A1 (de) * 2000-02-28 2001-09-06 Henkel Kgaa Verwendung von Flavonen oder Isoflavonen zur Cellulite-Behandlung
FR2836042A1 (fr) * 2002-02-15 2003-08-22 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour diminuer les poches et cernes sous les yeux
WO2004089392A1 (fr) * 2003-04-04 2004-10-21 Unigen Pharmaceuticals, Inc. Formulation destinee a inhiber la cyclooxygenase (cox) et la lipoxygenase (lox) utilisee dans les soins cutanes

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
AHN M-R, ET AL.: "Antioxidant activity and constituents of propolis collected in various areas of Korea", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 52, 11 February 2004 (2004-02-11), AMERICAN CHEMICAL SOCIETY, pages 7286 - 7292, XP002309669 *
ANONYMOUS: "Nutrasport Testroxin Gel", INTERNET ARTICLE, pages 1 - 2, XP002309667, Retrieved from the Internet <URL:http://www.bodybuilding-supplements-for-you.com/nutrasport/testroxin-gel.htm> *
DATABASE EMBASE [online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; 2002, WALLE U K ET AL: "Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids - Structural requirements", XP002309670, Database accession no. EMB-2002159263 *
DATABASE WPI Derwent World Patents Index; AN 2001-481491, XP002309671, CHEOUNG J H ET AL.: "Chrysin 7-o-crotonate, its producing method and composition useful for hair growth tonic" *
DRUG METABOLISM AND DISPOSITION 2002 UNITED STATES, vol. 30, no. 5, 2002, pages 564 - 569, ISSN: 0090-9556 *
INTERNATIONAL ANTIAGING SYSTEMS: "ESTROGEN BLOCKERS", INTERNET ARTICLE, pages 1 - 2, XP002309668, Retrieved from the Internet <URL:http://www.antiaging-systems.com/a2z/estrogenblock.htm> *
INTERNET ARTICLE, XP002312910, Retrieved from the Internet <URL:http://web.archive.org/web/*/http://www.bodybuilding-supplements-for-you.com/nutrasport/testroxin-gel.htm> *
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 14 5 March 2001 (2001-03-05) *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2898491A1 (fr) * 2006-03-16 2007-09-21 Seppic Sa Procede pour reduire l'odeur induite par les lipoaminoacides dans les formulations topiques cosmetiques et/ou pharmaceutiques et formulations a faible odeur
WO2007104898A3 (fr) * 2006-03-16 2007-11-01 Seppic Sa Procede pour reduire l'odeur induite par les lipoaminoacides dans les formulations topiques cosmetiques et/ou pharmaceutiques
FR2919501A1 (fr) * 2007-08-02 2009-02-06 Oreal Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
WO2009022077A2 (fr) 2007-08-02 2009-02-19 L'oreal Utilisation d'hespéridine ou de l'un de ses dérivés pour la prévention et/ou le traitement des peaux relâchées
WO2009022077A3 (fr) * 2007-08-02 2010-02-11 L'oreal Utilisation d'hespéridine ou de l'un de ses dérivés pour la prévention et/ou le traitement des peaux relâchées

Also Published As

Publication number Publication date
US20080213198A1 (en) 2008-09-04
EP1776161B1 (fr) 2016-10-26
US8530426B2 (en) 2013-09-10
WO2005102266A1 (fr) 2005-11-03
FR2869229B1 (fr) 2006-08-25
EP1776161A1 (fr) 2007-04-25

Similar Documents

Publication Publication Date Title
FR2869229A1 (fr) Utilisation d&#39;un inducteur des ugt par voie topique
DE60218458D1 (de) Isochinolinon derivate als parp inhibitoren
FR2825277B1 (fr) Composition cosmetique et/ou dermatologique et/ou pharmaceutique contenant au moins un compose ihnibiteur de l&#39;enzime 3, b-hsd
CL2004001174A1 (es) Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
DE50207442D1 (de) Behandlung der akne mit lipoxygenase inhibitoren
TNSN04211A1 (fr) Phenylacetamides substitues et leurs utilisation en tant qu&#39;activateurs de la glucokinase
FR2856294B1 (fr) Utilisation cosmetique d&#39;une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
ATE302005T1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
EP1188747A4 (fr) Compose de phenoxypropylamine
DE60117605D1 (de) Thiazolyl-inhibitoren von tyrosinkinasen der tec-familie
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
MA27334A1 (fr) Utilisation d&#39;inhibiteurs de l&#39;ikb kinase dans le traitement de la douleur
MXPA04004347A (es) Nuevos fotoindicadores difuncionales.
MA27181A1 (fr) Derives de thiazole et d&#39;oxazole qui modulent l&#39;activite de ppar.
DK1117403T3 (da) MGLUR5-antagonister til behandling af smerte og angst
EP1889604A3 (fr) Utilisation d&#39;un dérivé C-glycoside pour améliorer la fonction barrière de la peau
NO20035025L (no) Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet.
CL2004000366A1 (es) USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
FR2815541B1 (fr) Utilisation d&#39;inhibiteurs de l&#39;apoptose des pericytes pour le traitement et/ou la prevention de la retinopathie diabetique
FR2844715B1 (fr) Composition pour des soins de la peau, et contenant un ou des oligomeres de resveratrol, en particulier de l&#39;epsilone-viniferine, et ou certains de leurs derives
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
DE60233350D1 (de) IMIDAZOi2,1-B -1,3,4-THIADIAZOLE SULFONAMIDES
FR2902341B1 (fr) Utilisation therapeutique simultanee, separee ou etalee dans le temps d&#39;au moins une neurotoxine botulique, et d&#39;au moins un derive opiace
MA29145B1 (fr) Préparations pharmaceutiques pour le traitement de la cellulite

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20